Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

PROCODIN SYRUP

Approval Number

SIN04075P

Drug Name

PROCODIN SYRUP

Product Name

PROCODIN SYRUP

Approval Date

March 28, 1990

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Pharmacy Only

Formulation Information

Dosage Form

SYRUP

Route of Administration

ORAL

Medical Information

ATC Code

R05DA20

ATC Item Name

combinations

Manufacturer Information

Pharmaceutical Manufacturer

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Manufacturers

ICM PHARMA PTE. LTD.

Active Ingredients

Ingredient Name

CODEINE PHOSPHATE

Strength

9 mg/5 ml

Drug MonographCodeine

Ingredient Name

PROMETHAZINE HCl

Strength

3.6 mg/5 ml

Drug MonographPromethazine

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy